Inventor · disambiguated record
Pengyu Yang
Also filed as: YANG PENGYU
13 granted patents·11 pending applications·40 citations·filing 2014–2025
89Inventor score
Files withSCRIPPS RESEARCH INST10PLEXIUM INC7THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES4RAYTHERA INC2CALIFORNIA INST BIOMEDICAL RES1
Top patents by PatentIndex Score
24 records- 0196US11865160B2Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereofSCRIPPS RESEARCH INST·Filed 2021·Granted Jan 9, 2024·4 cites·10 claims
- 0293US12337028B2Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereofSCRIPPS RESEARCH INST·Filed 2023·Granted Jun 24, 2025·1 cites·9 claims
- 0390US10987427B2Modified therapeutic agents and compositions thereofSCRIPPS RESEARCH INST·Filed 2019·Granted Apr 27, 2021·4 cites·8 claims
- 0490US10039809B2Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereofTHE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES·Filed 2014·Granted Aug 7, 2018·12 cites·13 claims
- 0589US11007252B2Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereofSCRIPPS RESEARCH INST·Filed 2018·Granted May 18, 2021·6 cites·4 claims
- 0685US10286078B2Modified therapeutic agents and compositions thereofTHE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES·Filed 2014·Granted May 14, 2019·9 cites·8 claims
- 0784US11305288B2Assay devices for combinatorial librariesPLEXIUM INC·Filed 2020·Granted Apr 19, 2022·1 cites·9 claims
- 0882US2025235508A1Modified therapeutic agents and compositions thereofSCRIPPS RESEARCH INST·Filed 2024·Application pending·0 cites
- 0981US2025367259A1Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereofSCRIPPS RESEARCH INST·Filed 2025·Application pending·0 cites
- 1079US11878968B2Aryl compounds and pharmaceutical compositions that modulate IKZF2PLEXIUM INC·Filed 2022·Granted Jan 23, 2024·0 cites·40 claims
- 1177US2024246935A1Aryl compounds and pharmaceutical compositions that modulate ikzf2PLEXIUM INC·Filed 2023·Application pending·0 cites
- 1276US10351626B2Targeting agent antibody conjugates and uses thereofTHE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES·Filed 2014·Granted Jul 16, 2019·3 cites·8 claims
- 1373US11998919B2Assay devices for combinatorial librariesPLEXIUM INC·Filed 2022·Granted Jun 4, 2024·0 cites·10 claims
- 1473US2022396621A1Targeting agent antibody conjugates and uses thereofSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 1570US12410179B2Modulators of TNF alpha activity and uses thereofRAYTHERA INC·Filed 2024·Granted Sep 9, 2025·0 cites·16 claims
- 1670US2022072104A1Modified therapeutic agents and compositions thereofSCRIPPS RESEARCH INST·Filed 2021·Application pending·0 cites
- 1766US11377496B2Targeting agent antibody conjugates and uses thereofSCRIPPS RESEARCH INST·Filed 2019·Granted Jul 5, 2022·0 cites·1 claims
- 1864US2025263418A1Modulators of tnf alpha activity and uses thereofRAYTHERA INC·Filed 2025·Application pending·0 cites
- 1960US2024287037A1Cycloalkyl compounds and pharmaceutical compositions that modulate ikzf2PLEXIUM INC·Filed 2022·Application pending·0 cites
- 2060US2025100996A1Heterocycloalkyl and heteroaryl compounds and pharmaceutical compositions that modulate ikzf2PLEXIUM INC·Filed 2022·Application pending·0 cites
- 2157US2024148747A1Small molecule activators of yap transcriptional activity for regenerative organ repairSCRIPPS RESEARCH INST·Filed 2022·Application pending·0 cites
- 2256US11807620B2Quinazolinone compounds and related compoundsPLEXIUM INC·Filed 2021·Granted Nov 7, 2023·0 cites·24 claims
- 2350US2019000928A1Modified therapeutic agents and compositions thereofTHE CALIFORNIA INSTITUTE FOR BIOMEDICAL RES·Filed 2016·Application pending·0 cites
- 2450US2017002076A1Targeting agent antibody conjugates and uses thereofCALIFORNIA INST BIOMEDICAL RES·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pengyu Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →